0,05. Доказательная медицина от магии до поисков бессмертия

Brown-Sequard C. E. The effects produced on man by subcutaneous injections of a liquid obtained from the testicules of animals // Lancet. 1889. July 20. Vol. 2. P. 105–107.

Cussons A. J., Bhagat C. I., Fletcher S. J., Walsh J. P. Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment // The Medical Journal of Australia. 2002. December. Vol. 177. № 11. P. 678–679.

Matfin G. The rejuvenation of testosterone: philosopher’s stone or Brown-Séquard Elixir? // Therapeutic advances in endocrinology and metabolism. 2010. August. Vol. 1. № 4. P. 151–154.

Conway A. J., Handelsman D. J., Lording D. W., Stuckey B., Zajac J. D. Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing // The Medical Journal of Australia. 2000. March 6. Vol. 172. № 5. P. 220–224.

Clark W. C., Mehl L. Thermal pain: A sensory decision theory analysis of the effect of age and sex on d’ various response criteria, and 50% pain threshold // Journal of Abnormal Psychology. 1971. Vol. 78. № 2. P. 202–212.

Lewis S. C., Warlow C. P. How to spot bias and other potential problems in randomised controlled trials // Journal of Neurology, Neurosurgery & Psychiatry. Vol. 75. № 2. P. 181–187.

Hofer A., Hummer M., Huber R., Kurz M., Walch T., Fleischhacker W. W. Selection bias in clinical trials with antipsychotics // Journal of Clinical Psychopharmacology. 2000. December. Vol. 20. № 6. P. 699–702.

Hodges R. D., Scofield A. M. Is spiritual healing a valid and effective therapy? // Journal of the Royal Society of Medicine. 1995. Vol. 88. № 4. P. 203–207.

Abbot N. C., Harkness E. F., Stevinson C., Marshall F. P., Conn D. A., Ernst E. Spiritual healing as a therapy for chronic pain: a randomized, clinical trial // Pain. 2001. Vol. 91. № 1–2. P. 79–89.

Miller L. E., Stewart M. E. The blind leading the blind: Use and misuse of blinding in randomized controlled trials // Contemporary Clinical Trials. 2011. Vol. 32. № 2. P. 240–243.

Misra S. Randomized double blind placebo control studies, the “Gold Standard” in intervention based studies // Indian journal of sexually transmitted diseases and AIDS. 2012. July-December. Vol. 33. № 2. P. 131–134.

Jadad A. R., Enkin M. W. Randomized controlled trials: questions, answers, and musings. Blackwell Publishing, 2007.

George S. L. Perspectives on scientific misconduct and fraud in clinical trials // Chance. 1997. Vol. 10. № 4. P. 3–5.

Schulz K. F., Chalmers I., Hayes R. J., Altman D. G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials // JAMA. 1995. Vol. 273. № 5. P. 408–412.

Steneck N. H. Assessing the Integrity of Publicly Funded Research. A Background Report for the ORI Research Conference on Research Integrity. 2000.

George S. L., Buyse M. Data fraud in clinical trials // Clinical investigation. 2015. Vol. 5. № 2. P. 161–173.

Woodhead M. 80% of China’s clinical trial data are fraudulent, investigation finds // BMJ. 2016. Vol. 355: i5396.

Djulbegovic B., Lacevic M., Cantor A., Fields K. K., Bennett C. L., Adams J. R. et al. The uncertainty principle and industry-sponsored research // Lancet. 2000. August 19. Vol. 356. P. 635–638.

Lexchin J., Bero L. A., Djulbegovic B., Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review // BMJ. 2003. Vol. 326. P. 1167–1170.